CG211ZZ
Tomographic (Tomo) Nuclear Medicine Imaging Parathyroid Glands to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | G Endocrine System |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | 1 Parathyroid Glands |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
This family covers three-dimensional, rotational nuclear medicine scans of endocrine organs, most notably SPECT or SPECT/CT parathyroid localization and MIBG scanning of the adrenal glands. The gamma camera circles the patient to build a stack of cross-sectional slices, giving much sharper anatomic detail than a flat scan and allowing a small overactive gland to be pinpointed relative to surrounding structures.
Surgeons commonly request a parathyroid SPECT/CT before minimally invasive parathyroidectomy so they know exactly which of the four glands to remove. Adrenal MIBG scans, using an iodine-labeled tracer taken up by adrenal medullary tissue, help detect or stage a pheochromocytoma or neuroblastoma. These studies take longer than a basic planar scan because of the additional rotational acquisition time and post-processing needed to reconstruct the images.
Anatomy & Axis Detail
Parathyroid Glands
Because the parathyroid glands are small and their position relative to the thyroid varies considerably from one patient to the next, tomographic imaging adds cross-sectional localization that planar sestamibi imaging alone often cannot provide, particularly for glands that lie posteriorly, deep to the thyroid, or in ectopic mediastinal locations. SPECT, frequently combined with CT for anatomic correlation, allows a focus of retained tracer to be assigned confidently to a specific side and depth within the neck, information that directly guides a minimally invasive surgical approach rather than a bilateral neck exploration. This technique is especially valuable in patients with prior neck surgery or distorted anatomy, where planar images alone leave meaningful ambiguity about which gland is responsible for a biochemically confirmed hyperparathyroid state.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
The medical record must describe a rotational, multi-angle acquisition reconstructed into cross-sectional or three-dimensional images, ideally with the SPECT or SPECT/CT protocol named explicitly. Documentation of fused CT anatomy strengthens the case for this code but is not required if SPECT alone was performed. The most common coding pitfall is treating any parathyroid scan with delayed imaging as tomographic; many protocols are actually dual-phase planar studies with an early and late flat image, and the word "tomographic" appears nowhere in the technologist's actual acquisition parameters, only in loose radiologist phrasing.
Commonly Confused With
This family is most often mixed up with Planar Nuclear Medicine Imaging of the endocrine system, where the difference hinges entirely on whether cross-sectional reconstruction occurred. It can also be confused with therapeutic radiopharmaceutical administration, such as high-dose I-131 treatment for thyroid cancer, which is a treatment procedure in a different section rather than a diagnostic imaging study.